News | October 16, 2024
Wockhardt files fast-acting Insulin Aspart injection with DCGI
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
We now rank 3rd in pharmaceutical production by volume and 14th by value
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
CSPC will receive an upfront payment of $100 million from AstraZeneca
The acquisition will strengthen the overall company’s position as leading global CRO services partner
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Subscribe To Our Newsletter & Stay Updated
